Collaboration

Angle, NuProbe sign licensing agreement on NGS panel
By LabPulse.com staff writers
Liquid biopsy firm Angle has signed a licensing agreement with NuProbe to use NuProbe's next-generation sequencing (NGS) panel in its pan-cancer molecular sequencing assay.
September 23, 2024
Lab Pcr Tubes Dna Social
Bio-Rad, Sysmex America partner for QC in hemostasis systems
By LabPulse.com staff writers
Bio-Rad Laboratories and diagnostic test firm Sysmex America have formed a partnership in which Bio-Rad's Unity Next Peer QC software is offered with the Sysmex CA-Series and CS-Series hemostasis systems for coagulation testing.
September 24, 2024
Quality Check Mark Social
Roche adds new collaborative AI tools to cancer diagnostics open environment
By LabPulse.com staff writers
Roche is integrating more than 20 new artificial intelligence (AI) algorithms from eight new collaborators into its Roche Digital Pathology Open Environment for cancer diagnostics.
September 9, 2024
Ai Woman Social
Hitachi High-Tech, Gencurix forge agreement on cancer diagnostics
By LabPulse.com staff writers
Hitachi High-Tech and oncology molecular diagnostics firm Gencurix have formed a strategic partnership aimed at developing cancer diagnostics and testing services.
August 30, 2024
Hands Shaking2 Social
EDX, Caris sign molecular profiling distribution agreement
By LabPulse.com staff writers
Digital diagnostics developer EDX Medical Group and precision medicine company Caris Life Sciences have signed a distribution agreement for Caris' molecular profiling services.
September 3, 2024
Business Handshake Man Social
Qiagen ventures into chronic disease CDx
By LabPulse.com staff writers
Qiagen has expanded its agreement with AstraZeneca beyond oncology.
August 29, 2024
Business Handshake Intelligence Social
C2N, Unilabs sign global agreement on early Alzheimer's diagnostics
By LabPulse.com staff writers
C2N and Unilabs have signed a multiyear agreement that will increase access to C2N's Precivity blood tests for the early diagnosis of Alzheimer's disease to Unilabs' testing network on an exclusive basis.
August 8, 2024
Alzheimers Phases Amyloid Social
BURL Concepts, Bracco partner on ischemic stroke detection
By LabPulse.com staff writers
San Diego medical device firm BURL Concepts is collaborating with Bracco Imaging to produce BURL's SONAS device, a portable system for assessing ischemic strokes.
August 1, 2024
Brain Stroke Stroke Social
Nightingale Health, 23andMe partner on blood panel program
By LabPulse.com staff writers
Preventive health and risk-prediction company Nightingale Health and 23andMe have announced that they are joining up to offer a blood metabolomics panel to a group of 23andMe’s premium members through Nightingale’s Remote Health Check.
July 2, 2024
Blood Test Samples Lab Social
Radionetics Oncology, Lilly form strategic partnership
By LabPulse.com staff writers
Biotech firm Radionetics Oncology has entered a strategic partnership with Eli Lilly for access to Radionetics' proprietary G protein-coupled receptor-targeted small molecule radiopharmaceuticals for solid tumor treatment.
July 2, 2024
Business Men Handshake Social
Applied DNA, GenXys partner on pharmacogenomic test
By LabPulse.com staff writers
Applied DNA Sciences announced that its Applied DNA Clinical Labs molecular diagnostics subsidiary will use GenXys Health Care Systems' clinical decision support software for interpretation and reporting in its TR8 pharmacogenomic (TR8 PGx) test.
June 18, 2024
Cell Gene Therapy Dna Social
Myriad Genetics, GSK team up for global ovarian cancer testing
By LabPulse.com staff writers
Genetic testing and precision medicine company Myriad Genetics is collaborating with GSK to improve access to homologous recombination deficiency diagnostic testing for high-grade serous ovarian cancer patients in nine countries.
June 11, 2024
Ovarian Cancer2 Social
Page 1 of 41
Next Page